Advertisement
UK markets closed
  • NIKKEI 225

    40,580.76
    +506.07 (+1.26%)
     
  • HANG SENG

    17,978.57
    +209.43 (+1.18%)
     
  • CRUDE OIL

    83.06
    +0.25 (+0.30%)
     
  • GOLD FUTURES

    2,365.60
    +32.20 (+1.38%)
     
  • DOW

    39,308.00
    -23.85 (-0.06%)
     
  • Bitcoin GBP

    47,387.37
    -1,184.92 (-2.44%)
     
  • CMC Crypto 200

    1,299.35
    -35.57 (-2.66%)
     
  • NASDAQ Composite

    18,188.30
    +159.54 (+0.88%)
     
  • UK FTSE All Share

    4,463.09
    +33.43 (+0.75%)
     

Following recent decline, VSee Health, Inc.'s (NASDAQ:VSEE) top shareholder Co-Chief Executive Officer Imoigele Aisiku sees holdings value drop by 28%

Key Insights

  • Insiders appear to have a vested interest in VSee Health's growth, as seen by their sizeable ownership

  • The top 3 shareholders own 62% of the company

  • Using data from company's past performance alongside ownership research, one can better assess the future performance of a company

If you want to know who really controls VSee Health, Inc. (NASDAQ:VSEE), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 47% to be precise, is individual insiders. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

As a result, insiders as a group endured the highest losses after market cap fell by US$45m.

ADVERTISEMENT

Let's delve deeper into each type of owner of VSee Health, beginning with the chart below.

See our latest analysis for VSee Health

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About VSee Health?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Institutions have a very small stake in VSee Health. That indicates that the company is on the radar of some funds, but it isn't particularly popular with professional investors at the moment. So if the company itself can improve over time, we may well see more institutional buyers in the future. We sometimes see a rising share price when a few big institutions want to buy a certain stock at the same time. The history of earnings and revenue, which you can see below, could be helpful in considering if more institutional investors will want the stock. Of course, there are plenty of other factors to consider, too.

earnings-and-revenue-growth
earnings-and-revenue-growth

Hedge funds don't have many shares in VSee Health. Our data suggests that Imoigele Aisiku, who is also the company's Co-Chief Executive Officer, holds the most number of shares at 24%. When an insider holds a sizeable amount of a company's stock, investors consider it as a positive sign because it suggests that insiders are willing to have their wealth tied up in the future of the company. Milton Chen is the second largest shareholder owning 20% of common stock, and Digital Health Sponsor LLC holds about 18% of the company stock. Interestingly, the second-largest shareholder, Milton Chen is also Co-Chief Executive Officer, again, pointing towards strong insider ownership amongst the company's top shareholders.

To make our study more interesting, we found that the top 3 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

Insider Ownership Of VSee Health

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our most recent data indicates that insiders own a reasonable proportion of VSee Health, Inc.. It has a market capitalization of just US$129m, and insiders have US$60m worth of shares in their own names. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

General Public Ownership

The general public-- including retail investors -- own 32% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Private Company Ownership

We can see that Private Companies own 18%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with VSee Health , and understanding them should be part of your investment process.

If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com